Stefano Cafarotti retweeted
Most Popular: Highly Sensitive Detection of EGFR T790M Mutation in Pre-TKI Specimens of EGFR-Mutated NSCLC: I... bit.ly/PWswkJ
Stefano Cafarotti retweeted
Ceritinib Approved by FDA for ALK-Positive NSCLC targetedonc.com/articles/Cer…
Stefano Cafarotti retweeted
Ceritinib (Zykadia) - new drug for patients with ALK+ve NSCLC who progress on crizotinib (Xalkori) bit.ly/1rWUVFK
Stefano Cafarotti retweeted
Debate: Adjuvant therapy for resected node negative stage I NSCLC? - Sometimes fb.me/6tHiaGo79
Stefano Cafarotti retweeted
Most Popular: A Pooled Analysis of Limited-Stage Small-Cell Lung Cancer Patients Treated with Induction Chemot... bit.ly/14ESzNh
Stefano Cafarotti retweeted
Current ToC: Patterns of Failure after Stereotactic Body Radiation Therapy or Lobar Resection for Clinical Sta... bit.ly/19xQm9l
Stefano Cafarotti retweeted
Ahead-of-Print: Radiotherapy for Intubated Patients with Malignant Airway Obstruction: Futile or Facilitating ... bit.ly/19c0urC
Stefano Cafarotti retweeted
Combination maintenance therapy with erlotinib & bevacizumab offers little benefit for NSCLC patients: ow.ly/pBD7W
Stefano Cafarotti retweeted
Current ToC: Acute Autoimmune Hepatitis, Myositis, and Myasthenic Crisis in a Patient with Thymoma: No abstrac... bit.ly/1bWAeC2
Stefano Cafarotti retweeted
Ahead-of-Print: Screening High-Risk Populations for Lung Cancer: Guideline Recommendations: Introduction: The ... bit.ly/1cQCxa4
Stefano Cafarotti retweeted
Current ToC: Challenges to Implementation of an Epidermal Growth Factor Receptor Testing Strategy for Non-Smal... bit.ly/15HE00p
Stefano Cafarotti retweeted
Current ToC: Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non–Small-Cell Lung Can... bit.ly/1alVVOd
Stefano Cafarotti retweeted
Current ToC: Specificities of Lung Adenocarcinoma in Women Who Have Never Smoked: Introduction: No clear data ... bit.ly/154rXY0
Stefano Cafarotti retweeted
Current ToC: Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identificat... bit.ly/17F4Tll